The LIF cytokine: Towards adulthood

European Cytokine Network

Volumn 20, Issue 2, 2009, Pages 51-62

  Trouillas, Marina ^a   Saucourt, Claire ^a   Guillotin, Bertrand ^a   Gauthereau, Xavier ^a   Taupin, Jean Luc ^a   Moreau, Jean François ^a   Bœuf, Hélène ^a  

^a CNRS Bordeaux Segalen University   (France)

Author keywords

Chromatin; ES cells; IL 6; LIF; p531; Pleiotropy

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CARDIOTROPHIN 1; CILIARY NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR RECEPTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; GLYCOPROTEIN; INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 27; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; JANUS KINASE; KRUPPEL LIKE FACTOR 4; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; ONCOSTATIN M; ONCOSTATIN M RECEPTOR BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; SOMATOMEDIN B RECEPTOR; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR SOX2; UNINDEXED DRUG; VASCULOTROPIN;

CHROMATIN; EMBRYONIC STEM CELL; HUMAN; NONHUMAN; PLEIOTROPY; REVIEW; SCHWARTZ JAMPEL SYNDROME;

ANIMALS; CELL DIFFERENTIATION; EMBRYO IMPLANTATION; EMBRYONIC STEM CELLS; EXOSTOSES, MULTIPLE HEREDITARY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFERTILITY, FEMALE; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; MICE; OSTEOCHONDRODYSPLASIAS; PLURIPOTENT STEM CELLS; PREGNANCY; RECEPTORS, OSM-LIF; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

MURINAE;

EID: 67650662214     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2009.0148     Document Type: Review

References (207)

1. Taupin JL, Pitard V, Dechanet J, Miossec V, Gualde N, Moreau JF. Leukemia inhibitory factor: part of a large ingathering family. Int Rev Immunol 1998; 16: 397-426. (Pubitemid 28102262)
2. Metcalf D. The unsolved enigmas of leukemia inhibitory factor. Stem Cells 2003; 21: 5-14. (Pubitemid 36120360)
3. Shellard J, Perreau J, Brulet P. Role of leukemia inhibitory factor during mammalian development. Eur Cytokine Netw 1996; 7: 699-712. (Pubitemid 27056448)
4. Schere-Levy C, Buggiano V, Quaglino A, et al. Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp Cell Res 2003; 282: 35-47. (Pubitemid 36062610)
5. Kritikou EA, Sharkey A, Abell K, et al. A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development 2003; 130: 3459-3468 (Pubitemid 37010009)
6. Dhingra K, Sahin A, Emami K, Hortobagyi GN, Estrov Z. Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism. Breast Cancer Res Treat 1998; 48: 165-174 (Pubitemid 28156361)
7. Hu Y, Sun H, Drake J, Kittrell F, et al. From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies. Cancer Res 2004; 64: 7748-7755 (Pubitemid 39446906)
8. Wysoczynski M, Miekus K, Jankowski K, et al. Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Res 2007; 67: 2131-2140 (Pubitemid 46424232)
9. Duluc D, Delneste Y, Tan F, et al. Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 2007; 110: 4319-4330
10. Metcalfe SM, Muthukumarana PA, Thompson HL, Haendel MA, Lyons GE. Leukaemia inhibitory factor (LIF) is functionally linked to axotrophin and both LIF and axotrophin are linked to regulatory immune tolerance. FEBS Lett 2005; 579: 609-614
11. Muthukumarana PA, Lyons GE, Miura Y, et al. Evidence for functional inter-relationships between FOXP3, leukaemia inhibitory factor, and axotrophin/MARCH-7 in transplantation tolerance. Int Immunopharmacol 2006; 6: 1993-2001. (Pubitemid 44873101)
12. Mahic M, Kalland ME, Aandahl EM, Torgersen KM, Tasken K. Human naturally occurring and adaptive regulatory T cells secrete high levels of leukaemia inhibitory factor upon activation. Scand J Immunol 2008; 68: 391-396
13. Hu W, Feng Z, Teresky AK, Levine AJ. p53 regulates maternal reproduction through LIF. Nature 2007; 450: 721-724 (Pubitemid 350207678)
14. Stewart CL. Reproduction: the unusual suspect. Nature 2007; 450: 619.
15. Ichikawa Y. Differentiation of a cell line of myeloid leukemia. J Cell Physiol 1969; 74: 223-234
16. Maeda M, Horiuchi M, Numa S, Ichikawa Y. Characterization of a differentiation-stimulating factor for mouse myeloid leukemia cells. Gann 1977; 68: 435-447 (Pubitemid 8169889)
17. Abe E, Tanaka H, Ishimi Y, et al. Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption. Proc Natl Acad Sci USA 1986; 83: 5958-5962 (Pubitemid 16000633)
18. Koopman P, Cotton RG. A factor produced by feeder cells which inhibits embryonal carcinoma cell differentiation. Characterization and partial purification. Exp Cell Res 1984; 154: 233-242
19. Hilton DJ, Nicola NA, Gough NM, Metcalf D. Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine myeloid leukemic cell lines. J Biol Chem 1988; 263: 9238-9243 (Pubitemid 18160196)
20. Smith AG, Hooper ML. Buffalo rat liver cells produce a diffusible activity, which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol 1987; 121: 1-9. (Pubitemid 17076824)
21. Godard A, Gascan H, Naulet J, et al. Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood 1988; 71: 1618-1623 (Pubitemid 18165715)
22. Gearing DP, Gough NM, King J, et al. Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor. EMBO J 1987; 6: 3995-4002.
23. Moreau JF, Donaldson DD, Bennett F, Witek-Giannotti J, Clark SC, Wong GG. Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature 1988; 336: 690-692 (Pubitemid 19007953)
24. Gough NM, Gearing DP, King JA, et al. Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor. Proc Natl Acad Sci USA 1988; 85: 2623-2627
25. Baumann H, Wong GG. Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol 1989; 143: 1163-1167 (Pubitemid 19211341)
26. Elson GC, Lelievre E, Guillet C, et al. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci 2000; 3: 867-872 (Pubitemid 30677172)
27. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 2003; 374: 1-20. (Pubitemid 37046923)
28. Murakami M, Kamimura D, Hirano T. New IL-6 (gp130) family cytokine members, CLC/NNT1/BSF3 and IL-27. Growth Factors 2004; 22: 75-77
29. Vlotides G, Zitzmann K, Stalla GK, Auernhammer CJ. Novel neurotrophin-1/B cell-stimulating factor-3 (NNT-1/BSF-3)/cardiotrophin-like cytokine (CLC)-a novel gp130 cytokine with pleiotropic functions. Cytokine Growth Factor Rev 2004; 15: 325-336 (Pubitemid 39144382)
30. Rousseau F, Chevalier S, Guillet C, et al. Ciliary neurotrophic factor, cardiotrophin-like cytokine and neuropoietin share a conserved binding site on the ciliary neurotrophic factor receptor alpha chain. J Biol Chem 2008; 283: 30341-30350
31. Simpson RJ, Hilton DJ, Nice EC, et al. Structural characterization of a murine myeloid leukaemia inhibitory factor. Eur J Biochem 1988; 175: 541-547 (Pubitemid 18202037)
32. 2-terminal amino acid sequence of natural human interleukin for DA cells: leukemia inhibitory factor. Differentiation inhibitory activity secreted by a T lymphoma cell line. J Biol Chem 1989; 264: 21509-21515
33. Blanchard F, Raher S, Duplomb L, et al. The mannose 6-phosphate/insulin- like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor. J Biol Chem 1998; 273: 20886-20893 (Pubitemid 28385368)
34. Blanchard F, Duplomb L, Raher S, et al. Mannose 6-Phosphate/Insulin-like growth factor II receptor mediates internalization and degradation of leukemia inhibitory factor but not signal transduction. J Biol Chem 1999; 274: 24685-24693 (Pubitemid 129529351)
35. Rathjen PD, Toth S, Willis A, Heath JK, Smith AG. Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage. Cell 1990; 62: 1105-1114 (Pubitemid 20333770)
36. Haines BP, Voyle RB, Pelton TA, Forrest R, Rathjen PD. Complex conserved organization of the mammalian leukemia inhibitory factor gene: regulated expression of intracellular and extracellular cytokines. J Immunol 1999; 162: 4637-4646 (Pubitemid 29314863)
37. Haines BP, Voyle RB, Rathjen PD. Intracellular and extracellular leukemia inhibitory factor proteins have different cellular activities that are mediated by distinct protein motifs. Mol Biol Cell 2000; 11: 1369-1383 (Pubitemid 30211036)
38. Robertson M, Chambers I, Rathjen P, Nichols J, Smith A. Expression of alternative forms of differentiation inhibiting activity (DIA/LIF) during murine embryogenesis and in neonatal and adult tissues. Dev Genet 1993; 14: 165-173 (Pubitemid 23219915)
39. Hisaka T, Desmouliere A, Taupin JL, et al. Expression of leukemia inhibitory factor (LIF) and its receptor gp190 in human liver and in cultured human liver myofibroblasts. Cloning of new isoforms of LIF mRNA. Comp Hepatol 2004; 3: 10.
40. Heymann D, Rousselle AV. gp130 Cytokine family and bone cells. Cytokine 2000; 12: 1455-1468
41. Nasef A, Mazurier C, Bouchet S, et al. Leukemia inhibitory factor: role in human mesenchymal stem cells mediated immunosuppression. Cell Immunol 2008; 253: 16-22.
42. Viallard JF, Taupin JL, Miossec V, Pellegrin JL, Moreau BL. Analysis of interleukin-6, interleukin-10 and leukemia inhibitory factor (LIF) production by peripheral blood cells from patients with systemic lupus erythematosus identifies LIF as a potential marker of disease activity. Eur Cytokine Netw 1999; 10: 17-24. (Pubitemid 29158733)
43. Kerr BJ, Patterson PH. Potent pro-inflammatory actions of leukemia inhibitory factor in the spinal cord of the adult mouse. Exp Neurol 2004; 188: 391-407. (Pubitemid 38891600)
44. Pan W, Yu C, Hsuchou H, Zhang Y, Kastin AJ. Neuro-inflammation facilitates LIF entry into brain: role of TNF. Am J Physiol Cell Physiol 2008; 294: C1436-C1442.
45. Fujio Y, Matsuda T, Oshima Y, et al. Signals through gp130 upregulate Wnt5a and contribute to cell adhesion in cardiac myocytes. FEBS Lett 2004; 573: 202-206 (Pubitemid 39141058)
46. Stewart CL, Kaspar P, Brunet LJ, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992; 359: 76-79
47. Stewart CL. Leukaemia inhibitory factor and the regulation of pre-implantation development of the mammalian embryo. Mol Reprod Dev 1995; 39: 233-238
48. Song H, Lim H, Das SK, Paria BC, Dey SK. Dysregulation of EGF family of growth factors and COX-2 in the uterus during the pre-attachment and attachment reactions of the blastocyst with the luminal epithelium correlates with implantation failure in LIF-deficient mice. Mol Endocrinol 2000; 14: 1147-1161 (Pubitemid 32260477)
49. Szekeres-Bartho J, Wilczynski JR, Basta P, Kalinka J. Role of progesterone and progestin therapy in threatened abortion and preterm labour. Front Biosci 2008; 13: 1981-1990 (Pubitemid 351599750)
50. Bamberger AM, Jenatschke S, Schulte HM, Loning T, Bamberger MC. Leukemia inhibitory factor (LIF) stimulates the human HLA-G promoter in JEG3 choriocarcinoma cells. J Clin Endocrinol Metab 2000; 85: 3932-3936 (Pubitemid 30828611)
51. Metcalfe SM. Axotrophin and leukaemia inhibitory factor (LIF) in transplantation tolerance. Philos Trans R Soc Lond B Biol Sci 2005; 360: 1687-1694 (Pubitemid 43997817)
52. Bozec A, Bakiri L, Hoebertz A, et al. Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature 2008; 454: 221-225 (Pubitemid 351969891)
53. Metcalf D, Gearing DP. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci USA 1989; 86: 5948-5952 (Pubitemid 19217565)
54. Shen MM, Skoda RC, Cardiff RD, Campos-Torres J, Leder P, Ornitz DM. Expression of LIF in transgenic mice results in altered thymic epithelium and apparent interconversion of thymic and lymph node morphologies. EMBO J 1994; 13: 1375-1385 (Pubitemid 24090219)
55. Blais ME, Louis I, Perreault C. T-cell development: an extrathymic perspective. Immunol Rev 2006; 209: 103-114
56. Conquet F, Peyrieras N, Tiret L, Brulet P. Inhibited gastrulation in mouse embryos overexpressing the leukemia inhibitory factor. Proc Natl Acad Sci USA 1992; 89: 8195-8199
57. Shen MM, Leder P. Leukaemia inhibitory factor is expressed by the pre-implantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc Natl Acad Sci USA 1992; 89: 8240-8244
58. Smith AG, Heath JK, Donaldson DD, et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature 1988; 336: 688-690 (Pubitemid 19007952)
59. Smith AG. Embryo-derived stem cells: of mice and men. Annu Rev Cell Dev Biol 2001; 17: 435-462 (Pubitemid 33096183)
60. Niwa H. Molecular mechanism to maintain stem cell renewal of ES cells. Cell Struct Funct 2001; 26: 137-148 (Pubitemid 32894080)
61. Niwa H. How is pluripotency determined and maintained? Development 2007; 134: 635-646
62. Xu C, Inokuma MS, Denham J, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001; 19: 971-974 (Pubitemid 32947578)
63. Humphrey RK, Beattie GM, Lopez AD, et al. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 2004; 22: 522-530 (Pubitemid 39014568)
64. Vallier L, Reynolds D, Pedersen RA. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev Biol 2004; 275: 403-421 (Pubitemid 40288095)
65. Greber B, Lehrach H, Adjaye J. Control of early fate decisions in human ES cells by distinct states of TGFbeta pathway activity. Stem Cells Dev 2008; 17: 1065-1077
66. Dani C, Chambers I, Johnstone S, et al. Paracrine induction of stem cell renewal by LIF-deficient cells: a new ES cell regulatory pathway. Dev Biol 1998; 203: 149-162 (Pubitemid 28506670)
67. Richards M, Tan SP, Tan JH, Chan WK, Bongso A. The transcriptome profile of human embryonic stem cells as defined by SAGE. Stem Cells 2004; 22: 51-64. (Pubitemid 38018781)
68. Ginis I, Luo Y, Miura T, et al. Differences between human and mouse embryonic stem cells. Dev Biol 2004; 269: 360-380 (Pubitemid 38521104)
69. Brons IG, Smithers LE, Trotter MW, et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007; 448: 191-195 (Pubitemid 47067373)
70. Tesar PJ, Chenoweth JG, Brook FA, et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007; 448: 196-199 (Pubitemid 47067378)
71. Lengner C, Jaenish R. Pluripotent cell isolation for regenerative medecine. Nat Rev Mol Cell Biol 2008; 9 (Poster).
72. Boyer LA, Lee TI, Cole MF, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005; 122: 947-956 (Pubitemid 41345211)
73. Escary JL, Perreau J, Dumenil D, Ezine S, Brulet P. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 1993; 363: 361-364 (Pubitemid 23161534)
74. Holtmann B, Wiese S, Samsam M, et al. Triple knock-out of CNTF, LIF, and CT-1 defines cooperative and distinct roles of these neurotrophic factors for motoneuron maintenance and function. J Neurosci 2005; 25: 1778-1787 (Pubitemid 40279283)
75. Bugga L, Gadient RA, Kwan K, Stewart CL, Patterson PH. Analysis of neuronal and glial phenotypes in brains of mice deficient in leukemia inhibitory factor. J Neurobiol 1998; 36: 509-524 (Pubitemid 28402557)
76. Kim EJ, Simpson PJ, Park DJ, Liu BQ, Ronnett GV, Moon C. Leukemia inhibitory factor is a proliferative factor for olfactory sensory neurons. Neuroreport 2005; 16: 25-28 (Pubitemid 40194554)
77. Kubota Y, Hirashima M, Kishi K, Stewart CL, Suda T. Leukemia inhibitory factor regulates microvessel density by modulating oxygen-dependent VEGF expression in mice. J Clin Invest 2008; 118: 2393-2403 (Pubitemid 351949769)
78. Chen JR, Cheng JG, Shatzer T, Sewell L, Hernandez L, Stewart CL. Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. Endocrinology 2000; 141: 4365-4372 (Pubitemid 32055110)
79. Cheng TC, Huang CC, Chen CI, et al. Leukemia inhibitory factor antisense oligonucleotide inhibits the development of murine embryos at pre-implantation stages. Biol Reprod 2004; 70: 1270-1276 (Pubitemid 38509672)
80. Hu W, Feng Z, Atwal GS, Levine AJ. p53: a new player in reproduction. Cell Cycle 2008; 7: 848-852 (Pubitemid 351573775)
81. Pflanz S, Hibbert L, Mattson J, et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004; 172: 2225-2231 (Pubitemid 38182370)
82. Bando T, Morikawa Y, Komori T, Senba E. Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns. Neuroscience 2006; 142: 1263-1271 (Pubitemid 44636050)
83. Carl JW, Bai XF. IL27: its roles in the induction and inhibition of inflammation. Int J Clin Exp Pathol 2008; 1: 117-123
84. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997; 15: 797-819.
85. Bitard J, Daburon S, Duplomb L, et al. Mutations in the immunoglobulin-like domain of gp190, the leukemia inhibitory factor (LIF) receptor, increase or decrease its affinity for LIF. J Biol Chem 2003; 278: 16253-16261 (Pubitemid 36799750)
86. Giese B, Roderburg C, Sommerauer M, et al. Dimerization of the cytokine receptors gp130 and LIFR analyzed in single cells. J Cell Sci 2005; 118 (Pt 21): 5129-5140 (Pubitemid 41672443)
87. Tenhumberg S, Schuster B, Zhu L, et al. gp130 dimerization in the absence of ligand: Preformed cytokine receptor complexes. Biochem Biophys Res Commun 2006; 346: 649-657 (Pubitemid 43913672)
88. Huyton T, Zhang JG, Luo CS, et al. An unusual cytokine: Igdomain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor. Proc Natl Acad Sci USA 2007; 104: 12737-12742 (Pubitemid 47255224)
89. Skiniotis G, Lupardus PJ, Martick M, Walz T, Garcia KC. Structural organization of a full-length gp130/LIF-R cytokine receptor transmembrane complex. Mol Cell 2008; 31: 737-748
90. Auernhammer CJ, Melmed S. Leukemia-inhibitory factorneuro- immune modulator of endocrine function. Endocr Rev 2000; 21: 313-345 (Pubitemid 32275591)
91. Lehmann U, Schmitz J, Weissenbach M, et al. SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. J Biol Chem 2003; 278: 661-671 (Pubitemid 36043620)
92. Clahsen T, Lehmann U, Stross C, et al. The tyrosine 974 within the LIF-R-chain of the gp130/LIF-R heteromeric receptor complex mediates negative regulation of LIF signalling. Cell Signal 2005; 17: 559-569 (Pubitemid 40430959)
93. Li M, Sendtner M, Smith A. Essential function of LIF receptor in motor neurons. Nature 1995; 378: 724-727 (Pubitemid 26001944)
94. Ware CB, Horowitz MC, Renshaw BR, et al. Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995; 121: 1283-1299
95. Koblar SA, Turnley AM, Classon BJ, et al. Neural precursor differentiation into astrocytes requires signaling through the leukemia inhibitory factor receptor. Proc Natl Acad Sci USA 1998; 95: 3178-3181 (Pubitemid 28135875)
96. Yoshida K, Taga T, Saito M, et al. Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc Natl Acad Sci USA 1996; 93: 407-411 (Pubitemid 26041485)
97. Nichols J, Chambers I, Taga T, Smith A. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development 2001; 128: 2333-2339 (Pubitemid 32633366)
98. Fasnacht N, Muller W. Conditional gp130 deficient mouse mutants. Semin Cell Dev Biol 2008; 19: 379-384
99. Cullinan EB, Abbondanzo SJ, Anderson PS, Pollard JW, Lessey BA, Stewart CL. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/ paracrine function in regulating embryo implantation. Proc Natl Acad Sci USA 1996; 93: 3115-3120 (Pubitemid 26114373)
100. Pitard V, Lorgeot V, Taupin JL, Aubard Y, Praloran V, Moreau JF. The presence in human serum of a circulating soluble leukemia inhibitory factor receptor (sgp190) and its evolution during pregnancy. Eur Cytokine Netw 1998; 9: 599-605. (Pubitemid 29033926)
101. Delage G, Moreau JF, Taupin JL, et al. In vitro endometrial secretion of human interleukin for DA cells/leukaemia inhibitory factor by explant cultures from fertile and infertile women. Hum Reprod 1995; 10: 2483-2488
102. Chaouat G, Menu E, Delage G, et al. Immuno-endocrine interactions in early pregnancy. Hum Reprod 1995; 10 (Suppl 2): 55-59
103. Giess R, Tanasescu I, Steck T, Sendtner M. Leukaemia inhibitory factor gene mutations in infertile women. Mol Hum Reprod 1999; 5: 581-586 (Pubitemid 29251639)
104. Kralickova M, Sima R, Vanecek T, et al. Leukemia inhibitory factor gene mutations in the population of infertile women are not restricted to nulligravid patients. Eur J Obstet Gynecol Reprod Biol 2006; 127: 231-235 (Pubitemid 44189033)
105. Ledee-Bataille N, Lapree-Delage G, Taupin JL, Dubanchet S, Frydman R, Chaouat G. Concentration of leukaemia inhibitory factor (LIF) in uterine flushing fluid is highly predictive of embryo implantation. Hum Reprod 2002; 17: 213-218 (Pubitemid 34130289)
106. Dimitriadis E, Stoikos C, Stafford-Bell M, et al. Interleukin-11, IL-11 receptor alpha and leukemia inhibitory factor are dysregulated in endometrium of infertile women with endometriosis during the implantation window. J Reprod Immunol 2006; 69: 53-64. (Pubitemid 43144471)
107. Dagoneau N, Scheffer D, Huber C, et al. Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. Am J Hum Genet 2004; 74: 298-305. (Pubitemid 38168617)
108. Aubert J, Dessolin S, Belmonte N, et al. Leukemia inhibitory factor and its receptor promote adipocyte differentiation via the mitogen-activated protein kinase cascade. J Biol Chem 1999; 274: 24965-24972 (Pubitemid 129529389)
109. Rajasingh J, Bord E, Hamada H, et al. STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardio-myocyte pre-committed mES transplantation in a mouse model of myocardial infarction. Circ Res 2007; 101: 910-918 (Pubitemid 350287178)
110. Mohri T, Fujio Y, Maeda M, et al. Leukemia inhibitory factor induces endothelial differentiation in cardiac stem cells. J Biol Chem 2006; 281: 6442-6447 (Pubitemid 43847576)
111. Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell 2003; 115: 281-292 (Pubitemid 37487702)
112. Hao J, Li TG, Qi X, Zhao DF, Zhao GQ. WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev Biol 2006; 290: 81-91. (Pubitemid 43083605)
113. Ogawa K, Nishinakamura R, Iwamatsu Y, Shimosato D, Niwa H. Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochem Biophys Res Commun 2006; 343: 159-166
114. Oskowitz AZ, Lu J, Penfornis P, et al. Human multipotent stromal cells from bone marrow and microRNA: regulation of differentiation and leukemia inhibitory factor expression. Proc Natl Acad Sci USA 2008; 105: 18372-18377
115. Piquet-Pellorce C, Grey L, Mereau A, Heath JK. Are LIF and related cytokines functionally equivalent? Exp Cell Res 1994; 213: 340-347
116. Yoshida K, Chambers I, Nichols J, et al. Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech Dev 1994; 45: 163-171 (Pubitemid 24061363)
117. Rose TM, Weiford DM, Gunderson NL, Bruce AG. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro. Cytokine 1994; 6: 48-54. (Pubitemid 24120199)
118. Pennica D, Shaw KJ, Swanson TA, et al. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem 1995; 270: 10915-10922
119. DeChiara TM, Vejsada R, Poueymirou WT, et al. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 1995; 83: 313-322
120. Sendtner M, Gotz R, Holtmann B, et al. Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF. Curr Biol 1996; 6: 686-694 (Pubitemid 126656336)
121. Oppenheim RW, Wiese S, Prevette D, et al. Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J Neurosci 2001; 21: 1283-1291 (Pubitemid 32128773)
122. Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264: 95-98 (Pubitemid 24144493)
123. Hocke GM, Cui MZ, Fey GH. The LIF response element of the alpha-2-macroglobulin gene confers LIF-induced transcriptional activation in embryonal stem cells. Cytokine 1995; 7: 491-502.
124. Minami M, Inoue M, Wei S, et al. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci USA 1996; 93: 3963-3966 (Pubitemid 26144231)
125. Nakajima K, Yamanaka Y, Nakae K, et al. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 1996; 15: 3651-3658 (Pubitemid 26239777)
126. Boeuf H, Hauss C, Graeve FD, Baran N, Kedinger C. Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells. J Cell Biol 1997; 138: 1207-1217 (Pubitemid 27415048)
127. Niwa H, Burdon T, Chambers I, Smith A. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 1998; 12: 2048-2060 (Pubitemid 28323878)
128. Matsuda T, Nakamura T, Nakao K, et al. STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO J 1999; 18: 4261-4269 (Pubitemid 29364128)
129. Stahl N, Boulton TG, Farruggela T, et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL6b receptor components. Science 1994; 263: 92-95 (Pubitemid 24076263)
130. Stahl N, Farruggella TJ, Boulton TG, Zhong Z, Darnell JE Jr, Yancopoulos GD. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 1995; 267: 1349-1353
131. Ernst M, Oates A, Dunn AR. Gp130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. J Biol Chem 1996; 271: 30136-30143 (Pubitemid 26389655)
132. Chung BM, Kang HC, Han SY, et al. Jak2 and Tyk2 are necessary for lineage-specific differentiation, but not for the maintenance of self-renewal of mouse embryonic stem cells. Biochem Biophys Res Commun 2006; 351: 682-688 (Pubitemid 44780857)
133. Takahashi Y, Takahashi M, Carpino N, et al. Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway. Mol Endocrinol 2008; 22: 1673-1681 (Pubitemid 351920399)
134. Spangenburg EE, Booth FW. Multiple signaling pathways mediate LIF-induced skeletal muscle satellite cell proliferation. Am J Physiol Cell Physiol 2002; 283: C204-C211. (Pubitemid 34670564)
135. Naka T, Narazaki M, Hirata M, et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997; 387: 924-929 (Pubitemid 27289596)
136. Starr R, Willson TA, Viney EM, et al. A family of cytokineinducible inhibitors of signalling. Nature 1997; 387: 917-921
137. Hilton DJ. Negative regulators of cytokine signal transduction. Cell Mol Life Sci 1999; 55: 1568-1577 (Pubitemid 29445822)
138. Kile BT, Alexander WS. The suppressors of cytokine signalling (SOCS). Cell Mol Life Sci 2001; 58: 1627-1635
139. Lang R, Pauleau AL, Parganas E, et al. Murray, SOCS3 regulates the plasticity of gp130 signaling. Nat Immunol 2003; 4: 546-550
140. Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 2008; 19: 414-422
141. Piessevaux J, Lavens D, Peelman F, Tavernier J. The many faces of the SOCS box. Cytokine Growth Factor Rev 2008; 19: 371-381
142. Duval D, Reinhardt B, Kedinger C, Boeuf H. Role of suppressors of cytokine signaling (SOCS) in leukemia inhibitory factor (LIF)-dependent embryonic stem cell survival. FASEB J 2000; 14: 1577-1584 (Pubitemid 30636562)
143. Li Y, McClintick J, Zhong L, Edenberg HJ, Yoder MC, Chan RJ. Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood 2005; 105: 635-637 (Pubitemid 40070746)
144. Forrai A, Boyle K, Hart AH, et al. Absence of suppressor of cytokine signalling 3 reduces self-renewal and promotes differentiation in murine embryonic stem cells. Stem Cells 2006; 24: 604-614 (Pubitemid 44464764)
145. Takahashi Y, Carpino N, Cross JC, Torres M, Parganas E, Ihle JN. SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation. EMBO J 2003; 22: 372-384 (Pubitemid 36193583)
146. Boyle K, Robb L. The role of SOCS3 in modulating leukaemia inhibitory factor signalling during murine placental development. J Reprod Immunol 2008; 77: 1-6.
147. Sutherland KD, Vaillant F, Alexander WS, et al. c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3. EMBO J 2006; 25: 5805-5815 (Pubitemid 44967764)
148. Sutherland KD, Lindeman GJ, Visvader JE. The molecular culprits underlying precocious mammary gland involution. J Mammary Gland Biol Neoplasia 2007; 12: 15-23. (Pubitemid 46394922)
149. Muthukumarana P, Chae WJ, Maher S, Rosengard BR, Bothwell AL, Metcalfe SM. Regulatory transplantation tolerance and "stemness": evidence that Foxp3 may play a regulatory role in SOCS-3 gene transcription. Transplantation 2007; 84 (1 Suppl): S6-11.
150. Lord KA, Abdollahi A, Hoffman-Liebermann B, Liebermann DA. Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation. Mol Cell Biol 1993; 13: 841-851
151. Liebermann DA, Hoffman B. MyD genes in negative growth control. Oncogene 1998; 17: 3319-3329 (Pubitemid 29043984)
152. Nicholson SE, Willson TA, Farley A, et al. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J 1999; 18: 375-385 (Pubitemid 29041946)
153. Tone E, Kunisada K, Kumanogoh A, et al. gp130-dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation. Cytokine 2000; 12: 1512-1518 (Pubitemid 30786273)
154. Paling NR, Wheadon H, Bone HK, Welham MJ. Regulation of embryonic stem cell self-renewal by phosphoinositide 3- kinase-dependent signaling. J Biol Chem 2004; 279: 48063-48070 (Pubitemid 39540959)
155. Watanabe S, Umehara H, Murayama K, Okabe M, Kimura T, Nakano T. Activation of Akt signaling is sufficient to maintain pluripotency in mouse and primate embryonic stem cells. Oncogene 2006; 25: 2697-2707
156. Storm MP, Bone HK, Beck CG, et al. Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells. J Biol Chem 2007; 282: 6265-6273 (Pubitemid 47100902)
157. Burdon T, Smith A, Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 2002; 12: 432. (Pubitemid 35239952)
158. Boeuf H, Merienne K, Jacquot S, et al. The ribosomal S6 kinases, cAMP-responsive element-binding, and STAT3 proteins are regulated by different leukemia inhibitory factor signaling pathways in mouse embryonic stem cells. J Biol Chem 2001; 276: 46204-46211 (Pubitemid 37370873)
159. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 2007; 134: 2895-2902 (Pubitemid 47386902)
160. Lai WS, Parker JS, Grissom SF, Stumpo DJ, Blackshear PJ. Novel mRNA targets for tristetraprolin (TTP) identified by global analysis of stabilized transcripts in TTP-deficient fibroblasts. Mol Cell Biol 2006; 26: 9196-9208 (Pubitemid 44904416)
161. Trouillas M, Saucourt C, Guillotin B, et al. Three LIF-dependent signatures and gene clusters with atypical expression profiles, identified by transcriptome studies in mouse ES cells and early derivatives. BMC Genomics 2009; 10: 73.
162. Burdon T, Stracey C, Chambers I, Nichols J, Smith A. Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol 1999; 210: 30-43. (Pubitemid 29275085)
163. Sekkai D, Gruel G, Herry M, et al. Microarray analysis of LIF/Stat3 transcriptional targets in embryonic stem cells. Stem Cells 2005; 23: 1634-1642 (Pubitemid 41741013)
164. Duval D, Trouillas M, Thibault C, et al. Apoptosis and differentiation commitment: novel insights revealed by gene profiling studies in mouse embryonic stem cells. Cell Death Differ 2006; 13: 564-575
165. Cinelli P, Casanova EA, Uhlig S, et al. Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. BMC Dev Biol 2008; 8: 57. (Pubitemid 351793254)
166. Langlais D, Couture C, Balsalobre A, Drouin J. Regulatory network analyses reveal genome-wide potentiation of LIF signaling by glucocorticoids and define an innate cell defense response. PLoS Genet 2008; 4: e1000224.
167. Bourguignon LY, Peyrollier K, Xia W, Gilad E. Hyaluronan- CD44 interaction activates stem cell marker Nanog, Stat- 3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem 2008; 283: 17635-17651
168. Shafarenko M, Liebermann DA, Hoffman B. Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation. Blood 2005; 106: 871-878 (Pubitemid 41076426)
169. Gibbs JD, Liebermann DA, Hoffman B. Leukemia suppressor function of Egr-1 is dependent on transforming oncogene. Leukemia 2008; 22: 1909-1916
170. Piekorz RP, Blasius R, Fey GH, Hocke GM. Kinetics of the activation of the LIF-response factor in M1 myeloid leukemic cells. Ann NY Acad Sci 1995; 762: 452-454
171. Hirano T, Nakajima K, Hibi M. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev 1997; 8: 241-252 (Pubitemid 28202436)
172. Piekorz RP, Rinke R, Gouilleux F, Neumann B, Groner B, Hocke GM. Modulation of the activation status of Stat5a during LIF-induced differentiation of M1 myeloid leukemia cells. Biochim Biophys Acta 1998; 1402: 313-323 (Pubitemid 28206926)
173. Lee ER, McCool KW, Murdoch FE, Fritsch MK. Dynamic changes in histone H3 phosphoacetylation during early embryonic stem cell differentiation are directly mediated by mitogen- and stress-activated protein kinase 1 via activation of MAPK pathways. J Biol Chem 2006; 281: 21162-21172 (Pubitemid 44115456)
174. Lee ER, Murdoch FE, Fritsch MK. High histone acetylation and decreased polycomb repressive complex 2 member levels regulate gene specific transcriptional changes during early embryonic stem cell differentiation induced by retinoic acid. Stem Cells 2007; 25: 2191-2199 (Pubitemid 47480477)
175. McCool KW, Xu X, Singer DB, Murdoch FE, Fritsch MK. The role of histone acetylation in regulating early gene expression patterns during early embryonic stem cell differentiation. J Biol Chem 2007; 282: 6696-6706 (Pubitemid 47100906)
176. Karantzali E, Schulz H, Hummel O, Huebner N, Hatzopoulos A, Kretsovali A. Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis. Genome Biol 2008; 9: R65. (Pubitemid 351974312)
177. Boyer LA, Plath K, Zeitlinger J, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 2006; 441: 349-353 (Pubitemid 44050199)
178. Bernstein BE, Mikkelsen TS, Xie X, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006; 125: 315-326
179. Ura H, Usuda M, Kinoshita K, et al. STAT3 and Oct-3/4 control histone modification through induction of Eed in embryonic stem cells. J Biol Chem 2008; 283: 9713-9723
180. Meshorer E, Misteli T. Chromatin in pluripotent embryonic stem cells and differentiation. Nat Rev Mol Cell Biol 2006; 7: 540-546 (Pubitemid 44036459)
181. Loh YH, Zhang W, Chen X, George J, Ng HH. Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev 2007; 21: 2545-2557 (Pubitemid 47607666)
182. Shaked H, Shiff I, Kott-Gutkowski M, Siegfried Z, Haupt Y, Simon I. Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines. Cancer Res 2008; 68: 9671-9677
183. Vrba L, Junk DJ, Novak P, Futscher BW. p53 induces distinct epigenetic states at its direct target promoters. BMC Genomics 2008; 9: 486.
184. Cui S, Hope RM, Rathjen J, Voyle RB, Rathjen PD. Structure, sequence and function of a marsupial LIF gene: conservation of IL-6 family cytokines. Cytogenet Cell Genet 2001; 92: 271-278 (Pubitemid 32642006)
185. Horiuchi H, Furusawa S, Matsuda H. Maintenance of chicken embryonic stem cells in vitro. Methods Mol Biol 2006; 329: 17-34.
186. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development 2005; 132: 885-896 (Pubitemid 40484924)
187. Kidder BL, Yang J, Palmer S. Stat3 and c-Myc genome-wide promoter occupancy in embryonic stem cells. PLoS ONE 2008; 3: e3932.
188. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676 (Pubitemid 44233629)
189. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872 (Pubitemid 350138099)
190. Moon C, Yoo JY, Matarazzo V, Sung YK, Kim EJ, Ronnett GV. Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation. Proc Natl Acad Sci USA 2002; 99: 9015-9020 (Pubitemid 34693675)
191. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994; 368: 339-342 (Pubitemid 24104268)
192. Bernad A, Kopf M, Kulbacki R, Weich N, Koehler G, Gutierrez- Ramos JC. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1994; 1: 725-731
193. Morikawa Y, Tamura S, Minehata K, Donovan PJ, Miyajima A, Senba E. Essential function of oncostatin m in nociceptive neurons of dorsal root ganglia. J Neurosci 2004; 24: 1941-1947 (Pubitemid 38292806)
194. Masu Y, Wolf E, Holtmann B, Sendtner M, Brem G, Thoenen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature 1993; 365: 27-32. (Pubitemid 23305564)
195. Robb L, Li R, Hartley L, Nandurkar HH, Koentgen F, Begley CG. Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation. Nat Med 1998; 4: 303-308 (Pubitemid 28144088)
196. Robb L, Dimitriadis E, Li R, Salamonsen LA. Leukemia inhibitory factor and interleukin-11: cytokines with key roles in implantation. J Reprod Immunol 2002; 57: 129-141 (Pubitemid 35245744)
197. Tanaka M, Hirabayashi Y, Sekiguchi T, Inoue T, Katsuki M, Miyajima A. Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood 2003; 102: 3154-3162 (Pubitemid 37314751)
198. Nakamura K, Nonaka H, Saito H, Tanaka M, Miyajima A. Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 2004; 39: 635-644 (Pubitemid 38337643)
199. Oka M, Tagoku K, Russell TL, et al. CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. Mol Biol Cell 2002; 13: 1274-1281 (Pubitemid 34309622)
200. Lord KA, Abdollahi A, Thomas SM, et al. Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation. Mol Cell Biol 1991; 11: 4371-4379 (Pubitemid 21895831)
201. Matsumoto A, Masuhara M, Mitsui K, et al. CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation. Blood 1997; 89: 3148-3154 (Pubitemid 27229797)
202. Tomida M, Saito T. The human hepatocyte growth factor (HGF) gene is transcriptionally activated by leukemia inhibitory factor through the Stat-binding element. Oncogene 2004; 23: 679-686 (Pubitemid 38241268)
203. Sherwin JR, Freeman TC, Stephens RJ, et al. Identification of genes regulated by leukemia-inhibitory factor in the mouse uterus at the time of implantation. Mol Endocrinol 2004; 18: 2185-2195 (Pubitemid 39215249)
204. Manabe T, Fukuda K, Pan J, Nagasaki K, Yamaguchi K, Ogawa S. Hypertrophic stimuli augment expression of cMG1/ERF-1, a putative zinc-finger motif transcription factor, in rat cardiomyocytes. FEBS Lett 1999; 463: 39-42. (Pubitemid 30001714)
205. Laszlo GS, Nathanson NM. Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor. J Biol Chem 2003; 278: 27750-27757 (Pubitemid 36899965)
206. Turnley AM, Faux CH, Rietze RL, Coonan JR, Bartlett PF. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling. Nat Neurosci 2002; 5: 1155-1162 (Pubitemid 35247174)
207. Emery B, Cate HS, Marriott M, et al. Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proc Natl Acad Sci USA 2006; 103: 7859-7864 (Pubitemid 43752871)